Identification of ROS1 Rearrangement in Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Voss, S. M. [1 ]
Yang, Z. [1 ]
Zander, D. S. [1 ]
Bruggeman, R. [1 ]
Hollenbeak, C. S. [1 ]
Karamchandani, D. M. [1 ]
机构：
[1] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1873
引用
下载
收藏
页码：456A / 456A
页数：1
相关论文
共 50 条
  • [21] Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
    Mazieres, Julien
    Zalcman, Gerard
    Crino, Lucio
    Biondani, Pamela
    Barlesi, Fabrice
    Filleron, Thomas
    Dingemans, Anne-Marie C.
    Lena, Herve
    Monnet, Isabelle
    Rothschild, Sacha I.
    Cappuzzo, Federico
    Besse, Benjamin
    Thiberville, Luc
    Rouviere, Damien
    Dziadziuszko, Rafal
    Smit, Egbert F.
    Wolf, Jurgen
    Spirig, Christian
    Pecuchet, Nicolas
    Leenders, Frauke
    Heuckmann, Johannes M.
    Diebold, Joachim
    Milia, Julie D.
    Thomas, Roman K.
    Gautschi, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 992 - +
  • [22] ROS1 RNA In Situ Hybridization (RNA-ISH) for Detecting ROS1 Rearrangements in Lung Adenocarcinoma
    Helland, Timothy
    Neyaz, Azfar
    Deshpande, Vikram
    Hung, Yin
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1781 - 1781
  • [23] CLINICAL AND PROGNOSTIC IMPLICATION OF ALK AND ROS1 REARRANGEMENT IN NEVER SMOKER WITH SURGICALLY RESECTED LUNG ADENOCARCINOMA
    Kim, Hye Ryun
    Kim, Min Hwan
    Lim, Sun-Min
    Kim, Eun Young
    Park, Ji Soo
    Kim, Joo Hang
    Shim, Hyo Sup
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1220 - S1220
  • [24] A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant Activating EGFR Mutation and ROS1 Rearrangement
    Kim, Min Hwan
    Park, Yehyun
    Park, Hye Jung
    Ji, Ah-young
    Song, Changho
    Jin, Moo-Nyun
    Kim, Young Ju
    Kim, Sun Wook
    Lee, Jung-Hee
    Kim, In-Soo
    Kim, Hye Ryun
    Kim, Joohang
    Cho, Byoung Chul
    EWHA MEDICAL JOURNAL, 2014, 37 (01): : 46 - 51
  • [25] Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review
    Zhu, You-cai
    Lin, Xue-ping
    Li, Xiao-feng
    Wu, Li-xin
    Chen, Hua-fei
    Wang, Wen-xian
    Xu, Chun-wei
    Shen, Jian-fa
    Wei, Jian-guo
    Du, Kai-qi
    THORACIC CANCER, 2018, 9 (01) : 159 - 163
  • [26] High prevalence of ROS1 gene rearrangement detected by FISH in EGFR and ALK negative lung adenocarcinoma
    Xu, Yuyin
    Chang, Heng
    Wu, Lijing
    Zhang, Xin
    Zhang, Ling
    Zhang, Jing
    Li, Yuan
    Shen, Lei
    Zhu, Xiaoli
    Zhou, Xiaoyan
    Bai, Qianming
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 117
  • [27] ROS1 RNA In Situ Hybridization (RNA-ISH) for Detecting ROS1 Rearrangements in Lung Adenocarcinoma
    Helland, Timothy
    Neyaz, Azfar
    Deshpande, Vikram
    Hung, Yin
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1781 - 1781
  • [28] Complementary Utility of Combined ALK/ROS1 FISH with Immunohistochemistry for ALK/ROS1 Rearrangement Testing in Lung Cancer
    Nambirajan, A.
    Singh, V.
    Rana, D.
    Malik, P.
    Mohan, A.
    Jain, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1160 - S1160
  • [29] The frequency and impact of ROS1 rearrangement on clinical outcomes in CAM
    Dorta, Miriam
    Manuel Sepulveda, Juan
    Hernandez-Lain, Aurelio
    Velasco, Guillermo
    Manneh, Ray
    Ruano, Yolanda
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Identification of Inflammatory Subtypes of Pancreatic Ductal Adenocarcinoma
    不详
    PANCREAS, 2022, 51 (07) : 857 - 858
12345